These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 2820344)
1. Synaptophysin and neurofilament proteins as markers for neuroendocrine tumors. Miettinen M Arch Pathol Lab Med; 1987 Sep; 111(9):813-8. PubMed ID: 2820344 [TBL] [Abstract][Full Text] [Related]
2. Expression of intermediate filaments in neuroendocrine tumors. Kimura N; Nakazato Y; Nagura H; Sasano N Arch Pathol Lab Med; 1990 May; 114(5):506-10. PubMed ID: 2159272 [TBL] [Abstract][Full Text] [Related]
3. Synaptophysin expression in neuroendocrine neoplasms as determined by immunocytochemistry. Gould VE; Wiedenmann B; Lee I; Schwechheimer K; Dockhorn-Dworniczak B; Radosevich JA; Moll R; Franke WW Am J Pathol; 1987 Feb; 126(2):243-57. PubMed ID: 3103452 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical identification of neuron-specific enolase, synaptophysin, chromogranin and endocrine granule constituent in neuroendocrine tumours. Vyberg M; Horn T; Francis D; Askaa J Acta Histochem Suppl; 1990; 38():179-81. PubMed ID: 1964227 [TBL] [Abstract][Full Text] [Related]
5. Varying expression of cytokeratin and neurofilaments in neuroendocrine tumors of human gastrointestinal tract. Miettinen M; Lehto VP; Dahl D; Virtanen I Lab Invest; 1985 Apr; 52(4):429-36. PubMed ID: 2580121 [TBL] [Abstract][Full Text] [Related]
6. [Synaptophysin, chromogranin A and neuron-specific enolase as tumor markers in neuroendocrine tumors of the gastrointestinal tract and lung. An immunohistochemical study]. Eberlein-Gonska M; Wiedenmann B; Waldherr R Pathologe; 1989 Jul; 10(4):228-33. PubMed ID: 2549534 [No Abstract] [Full Text] [Related]
7. [Pheochromocytoma--pathohistologic and immunohistochemical aspects]. Tatić S; Havelka M; Paunović I; Bozić V; Diklic A; Brasanac D; Janković R; Jancić-Zguricas M Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():7-13. PubMed ID: 12584991 [TBL] [Abstract][Full Text] [Related]
8. Thyroid transcription factor-1 is expressed in extrapulmonary small cell carcinomas but not in other extrapulmonary neuroendocrine tumors. Agoff SN; Lamps LW; Philip AT; Amin MB; Schmidt RA; True LD; Folpe AL Mod Pathol; 2000 Mar; 13(3):238-42. PubMed ID: 10757334 [TBL] [Abstract][Full Text] [Related]
9. Microtubule-associated protein-2: a new sensitive and specific marker for pulmonary carcinoid tumor and small cell carcinoma. Liu Y; Sturgis CD; Grzybicki DM; Jasnosz KM; Olson PR; Tong M; Dabbs DD; Raab SS; Silverman JF Mod Pathol; 2001 Sep; 14(9):880-5. PubMed ID: 11557784 [TBL] [Abstract][Full Text] [Related]
10. Synaptophysin. A new marker for pancreatic neuroendocrine tumors. Chejfec G; Falkmer S; Grimelius L; Jacobsson B; Rodensjö M; Wiedenmann B; Franke WW; Lee I; Gould VE Am J Surg Pathol; 1987 Apr; 11(4):241-7. PubMed ID: 3032010 [TBL] [Abstract][Full Text] [Related]
11. Neuroendocrine differentiation in adrenocortical carcinoma. New immunohistochemical findings supported by electron microscopy. Miettinen M Lab Invest; 1992 Feb; 66(2):169-74. PubMed ID: 1735954 [TBL] [Abstract][Full Text] [Related]
12. Cytokeratin 7 and 20 and thyroid transcription factor 1 can help distinguish pulmonary from gastrointestinal carcinoid and pancreatic endocrine tumors. Cai YC; Banner B; Glickman J; Odze RD Hum Pathol; 2001 Oct; 32(10):1087-93. PubMed ID: 11679943 [TBL] [Abstract][Full Text] [Related]
13. Overlapping expression of immunohistochemical markers and synaptophysin mRNA in pheochromocytomas and adrenocortical carcinomas. Implications for the differential diagnosis of adrenal gland tumors. Komminoth P; Roth J; Schröder S; Saremaslani P; Heitz PU Lab Invest; 1995 Apr; 72(4):424-31. PubMed ID: 7723281 [TBL] [Abstract][Full Text] [Related]
14. Keratin 20: immunohistochemical marker for gastrointestinal, urothelial, and Merkel cell carcinomas. Miettinen M Mod Pathol; 1995 May; 8(4):384-8. PubMed ID: 7567935 [TBL] [Abstract][Full Text] [Related]
15. Detection of epithelial- and neural type of intermediate filament proteins in human lung tumors. Ramaekers F; Broers J; Rot MK; Oostendorp T; Wagenaar S; Vooijs P Acta Histochem Suppl; 1987; 34():45-56. PubMed ID: 3033739 [TBL] [Abstract][Full Text] [Related]
16. Paragangliomas of the head and neck: immunohistochemical neuroendocrine and intermediate filament typing. Johnson TL; Zarbo RJ; Lloyd RV; Crissman JD Mod Pathol; 1988 May; 1(3):216-23. PubMed ID: 2467285 [TBL] [Abstract][Full Text] [Related]
17. Aberrant expression of human achaete-scute homologue gene 1 in the gastrointestinal neuroendocrine carcinomas. Shida T; Furuya M; Nikaido T; Kishimoto T; Koda K; Oda K; Nakatani Y; Miyazaki M; Ishikura H Clin Cancer Res; 2005 Jan; 11(2 Pt 1):450-8. PubMed ID: 15701827 [TBL] [Abstract][Full Text] [Related]
18. Serine protease inhibitor 8 is a novel immunohistochemical marker for neuroendocrine tumors of the pancreas. de Koning PJ; Bovenschen N; Broekhuizen R; Lips CJ; Kummer JA Pancreas; 2009 May; 38(4):461-7. PubMed ID: 19188865 [TBL] [Abstract][Full Text] [Related]
19. Spindle-cell neuroendocrine carcinomas of the thymus (spindle-cell thymic carcinoid): a clinicopathologic and immunohistochemical study of seven cases. Moran CA; Suster S Mod Pathol; 1999 Jun; 12(6):587-91. PubMed ID: 10392634 [TBL] [Abstract][Full Text] [Related]
20. Selective expression of trophoblastic hormones by lung carcinoma: neurendocrine tumors exclusively produce human chorionic gonadotropin alpha-subunit (hCGalpha). Dirnhofer S; Freund M; Rogatsch H; Krabichler S; Berger P Hum Pathol; 2000 Aug; 31(8):966-72. PubMed ID: 10987258 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]